Bramhansh is a commercial health tech startup advancing the field of neurostimulation.

Bramhansh’s patented technology platform leverages neuro-stimulation on the trigeminal, sympathetic, and vagus nerve structures.

Bramhansh’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications.

Bramhansh’s first commercial product MIGRAELIEF is an CDSCO registered, award-winning, wearable bioelectronic migraine relief device. MIGRAELIEF is clinically proven, doctor recommended, and is available through online retailers and commercial distributors.

Bramhansh's mission is to advance neurostimulation to improve health, fight disease, and increase vibrancy of life!